IACH News Podcasts

Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access.

May 12th- Prof. Christian Chabannon - Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial

CME Congresses .

May 12th- Prof. Christian Chabannon – Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial

April 30th- Dr. Anne-Marie Becking- Zanubrutinib in Bing Neel syndrome: efficacy and tolerability

CME Congresses .

April 30th- Dr. Anne-Marie Becking- Zanubrutinib in Bing Neel syndrome: efficacy and tolerability

April 25th- Dr. Guillermo Manero Garicia-The COMMANDS study from #ASH24

CME Congresses .

April 25th- Dr. Guillermo Manero Garicia-The COMMANDS study from #ASH24

March 25th- Dr. Jian Zhou- Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases

CME Congresses .

March 25th- Dr. Jian Zhou- Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases

March 20th - Dr. Emily Liang- Development and validation of predictive models of early immune effector cell–associated hematotoxicity

CME Congresses .

March 20th Dr. Emily Liang- Development and validation of predictive models of early immune effector cell–associated hematotoxicity

March 4th- Dr. Eli Muchtar- Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy

CME Congresses .

March 4th – Dr. Eli Muchtar- Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy

Feb 19th - Prof. Maria Teresa Voso- Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

CME Congresses .

Feb 19th – Prof. Maria Teresa Voso- Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

Feb 9th - Prof. Rahul Banerjee- Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis

CME Congresses .

Feb 9th – Prof. Rahul Banerjee- Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis

Feb 3rd- Prof. Ahraf Badros- Daratumumab with Lenalidomide as Maintenance After Transplant in Newly Diagnosed Multiple Myeloma: the AURIGA Study

CME Congresses .

Feb 3rd- Prof. Ahraf Badros- Daratumumab with Lenalidomide as Maintenance After Transplant in Newly Diagnosed Multiple Myeloma: the AURIGA Study

January 19th 2025- Dr. Rohtesh Mehta- Haploidentical vs HLA-Matched Sibling Donor HCT with PTCy Prophylaxis: HLA Factors and Donor Age Considerations

CME Congresses .

January 19th 2025- Dr. Rohtesh Mehta- Haploidentical vs HLA-Matched Sibling Donor HCT with PTCy Prophylaxis: HLA Factors and Donor Age Considerations